Preparation of DNA-loaded chitosan nanoparticle vaccine
-
摘要: 目的 制备负载抗龋DNA疫苗pVAX1-wapA质粒的壳聚糖和季铵化壳聚糖纳米粒,优化其制备工艺,测定其细胞转染效率。 方法 以包封率和粒径为主要指标,单因素法考察载体浓度、pH值、N/P、TPP浓度等因素的影响,Realtime-PCR检测细胞对质粒编码蛋白的转录表达水平以评价载质粒纳米粒的促转染作用。 结果 制得的载DNA疫苗纳米粒粒径均一,形态圆整。壳聚糖(CS)纳米粒粒径为(219.2±18.2) nm,Zeta电位为(24.7±3.5) mV,包封率为91.24%。季铵化壳聚糖(CSTM)纳米粒粒径为(222.5±15.6) nm,Zeta电位为(19.6±1.2) mV,包封率为87.66%。纳米粒可以促进pVAX1-wapA进入细胞,并成功被转录。 结论 制备的包载pVAX1-wapA的季铵化壳聚糖纳米粒可用于重组基因疫苗的运送。Abstract: Objective To study and optimize the preparation condition of pVAX1-wapA-loaded nanoparticles and determine the transfection efficiency. Methods The related effects of the crucial factors for the formation of nanoparticles: concentration of chitosan and TPP, pH value, N/P ratio were studied by single-factor experiment, with nanoparticles size and zeta potential as index. Cell transfection test was carried out to indicate that enhancement of cell transfection efficiency of nano-carrier. Results Nanoparticles loaded DNA vaccine were nearly spherical shape with uniform particle size chitosan nanoparticle(CS),(219.2±18.2) nm;quaternary ammonium chitosan nanoparticles(CSTM),(222.5±15.6) nm. Zeta potential of CS and CSTM was (24.7±3.5) mV, (19.6±1.2) mV and encapsulation efficiency was 91.24%, 87.66%,respectively.CSTM nanoparticle could enhance cellular uptake of pVAX1-wapA obviously. Conclusion CSTM nanoparticle was proved to be an efficient DNA vaccine delivery vector.
-
Key words:
- DNA vaccine /
- chitosan nanoparticle /
- wapA protein /
- transfection /
- quaternary ammonium chitosan
-
[1] 樊明文,边 专. 防龋疫苗主动免疫的现状与未来[J]. 中华口腔医学杂志, 2002,37(6):401-403. [2] 刘善奎,高 申,钟延强,等. DNA 疫苗微球给药系统的研究进展[J]. 中国药学杂志,2004,38(11):828-831. [3] 白 枫,孙大庆. DNA疫苗递送系统研究进展[J]. 国际免疫学杂志,2008,31(3):236-239. [4] 李艳红,胡四海. 壳聚糖纳米粒介导基因转染的影响因素及改性修饰[J]. 微生物学免疫学进展,2010,38(3):50-53. [5] Erbacher P,Zou S, Bettinger T,et al. Chitosan-based vector/DNA complexes for gene delivery: Biophysical Characteristics and Transfection Ability[J].Pharm Res,1998,15(9):1332-1339. [6] Lee M,Nah JW,Kwon Y,et al. Water-soluble and low molecular weight chitosan-based plasmid DNA delivery[J]. Pharm Res,2001,18(4):427-431. [7] Ishii T,Okahata Y,Sato T. Mechanism of cell transfection with plasmid/chitosan complexes[J]. Biochim Biophys Acta,2001,1514(1):51-64. [8] Huang M,Fong CW,Khor E,et al. Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation[J]. J Control Release,2005,106(3):391-406. [9] 杨晓容,宗 莉,朱敏艳,等. 荧光探针示踪pDNA/壳聚糖纳米粒在细胞内转运[J].中国药学杂志,2009,43(10):727-731. [10] 王江峰,鲁 莹,黄景彬,等.聚氨基酯载基因纳米粒的研究[J].第二军医大学学报,2011,32(5):473-476. [11] Qian F,Cui F,Ding J,et al. Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization[J].Biomacromolecules,2006,7(10):2722-2727. [12] 刘世伟，孙 逊，聂 宇，等。载基因壳聚糖纳米粒的制备及 其相关性质的初步研究[J].华西药学杂志，2005,19 (6):409-411. [13] Mao HQ,Roy K,Troung-Le VL,et al.Chitosan-DNA nano-particles as gene carriers: synthesis, characterization and transfection efficiency [J]. J Control Release,2001,70 (3): 399-421. [14] Goldmann K,Ensminger SM,Spriewald BM.Oral gene appli-cation using chitosan-DNA nanoparticles induces transferable tolerance[J].Clin Vaccine Immunol,2012,19 (11):1758-1764. -
点击查看大图
计量
- 文章访问数: 3669
- HTML全文浏览量: 272
- PDF下载量: 134
- 被引次数: 0
下载:
